Vera Therapeutics (VERA) Enterprise Value (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Enterprise Value came in at -$596.8 million in Q1 2026, down 1.17% YoY from -$603.9 million in Q1 2025, and up 16.49% on a QoQ basis from -$714.6 million in Q4 2025.
Vera Therapeutics (VERA) Enterprise Value (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Enterprise Value data on file, last reported at -$596.8 million in Q1 2026.
- Quarterly Enterprise Value fell 1.17% year-over-year to -$596.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$596.8 million (down 1.17% YoY) and the FY2025 annual result came in at -$714.6 million, down 11.51% from the prior year.
- Enterprise Value rose to -$596.8 million in Q1 2026, from -$714.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$114.4 million in Q3 2022 to a low of -$714.6 million in Q4 2025.
- A 5-year average of -$349.9 million and a median of -$353.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value tumbled 298.75% — and 2026, when it slipped 1.17%.
- Tracing VERA's Enterprise Value over 5 years: stood at -$114.7 million in 2022, then sank by 40.18% to -$160.7 million in 2023, then plunged by 298.75% to -$640.9 million in 2024, then decreased by 11.51% to -$714.6 million in 2025, then rose by 16.49% to -$596.8 million in 2026.
- The last three Enterprise Value figures came in at -$596.8 million (Q1 2026), -$714.6 million (Q4 2025), and -$497.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | -499.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -499.16 Mn |
| Mar 31, 2026 | -596.76 Mn |
| Dec 31, 2025 | -714.59 Mn |
| Sep 30, 2025 | -497.39 Mn |
| Jun 30, 2025 | -556.83 Mn |
| Mar 31, 2025 | -589.83 Mn |
| Dec 31, 2024 | -640.85 Mn |
| Sep 30, 2024 | -353.31 Mn |
| Jun 30, 2024 | -384.39 Mn |
| Mar 31, 2024 | -403.66 Mn |
| Dec 31, 2023 | -160.72 Mn |
| Sep 30, 2023 | -159.94 Mn |
| Jun 30, 2023 | -181.02 Mn |
| Mar 31, 2023 | -197.15 Mn |
| Dec 31, 2022 | -114.65 Mn |
| Sep 30, 2022 | -114.42 Mn |
| Jun 30, 2022 | -131.93 Mn |
| Mar 31, 2022 | -150.94 Mn |
| Dec 31, 2021 | -79.67 Mn |
| Sep 30, 2021 | -86.25 Mn |